Incannex Healthcare Inc. Investing Cash Flow
Incannex Healthcare Inc. (IXHL) reported Investing Cash Flow of -$64.00 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-05-15
- Incannex Healthcare Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$18.00K.
- Incannex Healthcare Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$4.00K.
- Incannex Healthcare Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$42.00K.
- Incannex Healthcare Inc. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $0.00.
- Incannex Healthcare Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$8.00K.
- Incannex Healthcare Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$277.00K.
- Incannex Healthcare Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$316.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$22.00K derived: sum of 2 quarters · filed 2026-05-15 | -$64.00K 10-Q · filed 2026-05-15 | -$64.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | -$46.00K 10-Q · filed 2026-02-13 | -$46.00K derived: sum of 3 quarters · filed 2026-02-13 | -$46.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-09-30 | -$42.00K 10-Q · filed 2025-11-14 | -$42.00K derived: sum of 2 quarters · filed 2025-11-14 | -$42.00K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | -$8.00K 10-K · filed 2025-09-29 | |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$8.00K 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | -$8.00K 10-Q · filed 2026-02-13 | |||
| 2024-06-30 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $3.00K derived: sum of 2 quarters · filed 2025-09-29 | -$56.00K derived: sum of 3 quarters · filed 2025-09-29 | -$277.00K 10-K · filed 2025-09-29 |
| 2024-03-31 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | -$53.00K derived: sum of 2 quarters · filed 2025-05-15 | -$274.00K 10-Q · filed 2025-05-15 | -$445.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | -$280.00K 10-Q · filed 2025-02-14 | -$451.00K derived: sum of 3 quarters · filed 2025-02-14 | -$483.00K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | -$221.00K 10-Q · filed 2024-11-14 | -$392.00K derived: sum of 2 quarters · filed 2024-11-14 | -$424.00K derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$203.00K derived: sum of 2 quarters · filed 2024-09-30 | -$316.00K 10-K · filed 2024-09-30 | |
| 2023-03-31 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$145.00K 10-Q · filed 2024-05-15 | ||
| 2022-12-31 | -$113.00K 10-Q · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |